Your browser doesn't support javascript.
loading
Reprogramming the tumor metastasis cascade by targeting galectin-driven networks.
Perrotta, Ramiro M; Bach, Camila A; Salatino, Mariana; Rabinovich, Gabriel A.
Afiliação
  • Perrotta RM; Laboratorio de Inmunopatología, Instituto de Biología y Medicina Experimental (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), C1428ADN Buenos Aires, Argentina.
  • Bach CA; Laboratorio de Inmunopatología, Instituto de Biología y Medicina Experimental (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), C1428ADN Buenos Aires, Argentina.
  • Salatino M; Laboratorio de Inmunopatología, Instituto de Biología y Medicina Experimental (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), C1428ADN Buenos Aires, Argentina.
  • Rabinovich GA; Laboratorio de Inmunopatología, Instituto de Biología y Medicina Experimental (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), C1428ADN Buenos Aires, Argentina.
Biochem J ; 478(3): 597-617, 2021 02 12.
Article em En | MEDLINE | ID: mdl-33600595
ABSTRACT
A sequence of interconnected events known as the metastatic cascade promotes tumor progression by regulating cellular and molecular interactions between tumor, stromal, endothelial, and immune cells both locally and systemically. Recently, a new concept has emerged to better describe this process by defining four attributes that metastatic cells should undergo. Every individual hallmark represents a unique trait of a metastatic cell that impacts directly in the outcome of the metastasis process. These critical features, known as the hallmarks of metastasis, include motility and invasion, modulation of the microenvironment, cell plasticity and colonization. They are hierarchically regulated at different levels by several factors, including galectins, a highly conserved family of ß-galactoside-binding proteins abundantly expressed in tumor microenvironments and sites of metastasis. In this review, we discuss the role of galectins in modulating each hallmark of metastasis, highlighting novel therapeutic opportunities for treating the metastatic disease.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Galectinas / Metástase Neoplásica / Proteínas de Neoplasias Limite: Animals / Humans Idioma: En Revista: Biochem J Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Argentina

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Galectinas / Metástase Neoplásica / Proteínas de Neoplasias Limite: Animals / Humans Idioma: En Revista: Biochem J Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Argentina